Sls Clinical Research Consulting, is categorized under Business Consultants in Pine Brook, NJ and active since 2012.
Sls Clinical Research Consulting, was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Sylvia L Santos at the company’s single location by writing to 3 Normandy Road, Pine Brook, New Jersey NJ 07058 or by phoning (973) 808-6809. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sls Clinical Research Consulting, |
| Contact Person: | Sylvia L Santos |
| Address: | 3 Normandy Road, Pine Brook, New Jersey 07058 |
| Phone Number: | (973) 808-6809 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Sls Clinical Research Consulting, was started in 2012 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Sylvia L Santos for inquiries that concern Sls Clinical Research Consulting, by calling the company number (973) 808-6809, as your correspondence is most welcome. Additionally, the physical location of the single location of Sls Clinical Research Consulting, can be found at the coordinates 40.871936,-74.354053 as well as the street address 3 Normandy Road in Pine Brook, New Jersey 07058.
For its online presence, you may visit Sls Clinical Research Consulting,’s website at and engage with its social media outlets through on Twitter and on Facebook.